Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2026-02-22 @ 6:46 PM
Study NCT ID:
NCT02705859
Status:
COMPLETED
Last Update Posted:
2025-01-09
First Post:
2016-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)
Sponsor:
Cancer Trials Ireland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04
Start Date Type:
None
Primary Completion Date:
2021-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-11
First Submit QC Date:
None
Study First Post Date:
2016-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-08
Last Update Post Date:
2025-01-09
Last Update Post Date Type:
ACTUAL